Physiciansʼ Guide to Interactions Between Glaucoma and Systemic Medications
PURPOSETo develop a Physiciansʼ Guide to assist clinicians in the concomitant use of glaucoma and systemic medications. METHODSThe records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed i...
Gespeichert in:
| Veröffentlicht in: | Journal of glaucoma 1997-12, Vol.6 (6), p.377-383 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 383 |
|---|---|
| container_issue | 6 |
| container_start_page | 377 |
| container_title | Journal of glaucoma |
| container_volume | 6 |
| creator | Gottfredsdottir, Maria S Allingham, R Rand Shields, M Bruce |
| description | PURPOSETo develop a Physiciansʼ Guide to assist clinicians in the concomitant use of glaucoma and systemic medications.
METHODSThe records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed in this population. The ten most common drug classes were then used to construct a guide to potential interactions and side effects when these medications are used concomitantly with glaucoma drugs.
RESULTSEighty-four patients were receiving 1 or more medications (a mean of 3.5) for a mean of 2.6 systemic conditions. Systemic antihypertensive agents was the most common class of drugs, being used by 48 patients. Aspirin, the most common single systemic drug, was being used by 25 patients.
CONCLUSIONSA high percentage of patients with chronic open-angle glaucoma receive a wide variety of medications for coexisting systemic disorders. The concomitant use of glaucoma and systemic medications creates the potential for drug interactions, as well as side effects for both groups of drugs, for which the Physiciansʼ Guide may be beneficial. |
| doi_str_mv | 10.1097/00061198-199712000-00007 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00061198_199712000_00007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9407366</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4217-14d66399b9d682fa6c1a1784e5835c294aeb89619cc3f77a31668ad4cd1ab7363</originalsourceid><addsrcrecordid>eNp1kN1KAzEQhYMotVYfQcgLrGaSbH4utWgtVBRU8C5kkyxd3Z-y2aX03XwCn8q1rb3zYpgZzpzD8CGEgVwB0fKaECIAtEpAawl0WJOhiDxCY0iZSLiC9-NhJqlMiKL6FJ3F-EEIJZTCCI00J5IJMUaL5-UmFq6wdfz-wrO-8AF3DZ7XXWit64qmjvg2dOsQajwrbe-aymJbe_yyiV2oCocfgy-c3V6eo5PcljFc7PsEvd3fvU4fksXTbD69WSSOU5AJcC8E0zrTXiiaW-HAglQ8pIqljmpuQ6a0AO0cy6W0DIRQ1nPnwWbD22yC1C7XtU2MbcjNqi0q224MEPPLx_zxMQc-ZstnsF7urKs-q4I_GPdABp3v9HVTDgjiZ9mvQ2uWwZbd0vyHnf0Ad0Zwwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Physiciansʼ Guide to Interactions Between Glaucoma and Systemic Medications</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Gottfredsdottir, Maria S ; Allingham, R Rand ; Shields, M Bruce</creator><creatorcontrib>Gottfredsdottir, Maria S ; Allingham, R Rand ; Shields, M Bruce</creatorcontrib><description>PURPOSETo develop a Physiciansʼ Guide to assist clinicians in the concomitant use of glaucoma and systemic medications.
METHODSThe records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed in this population. The ten most common drug classes were then used to construct a guide to potential interactions and side effects when these medications are used concomitantly with glaucoma drugs.
RESULTSEighty-four patients were receiving 1 or more medications (a mean of 3.5) for a mean of 2.6 systemic conditions. Systemic antihypertensive agents was the most common class of drugs, being used by 48 patients. Aspirin, the most common single systemic drug, was being used by 25 patients.
CONCLUSIONSA high percentage of patients with chronic open-angle glaucoma receive a wide variety of medications for coexisting systemic disorders. The concomitant use of glaucoma and systemic medications creates the potential for drug interactions, as well as side effects for both groups of drugs, for which the Physiciansʼ Guide may be beneficial.</description><identifier>ISSN: 1057-0829</identifier><identifier>EISSN: 1536-481X</identifier><identifier>DOI: 10.1097/00061198-199712000-00007</identifier><identifier>PMID: 9407366</identifier><language>eng</language><publisher>United States: Williams & Wilkins</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Anticoagulants - therapeutic use ; Antihypertensive Agents - therapeutic use ; Carbonic Anhydrase Inhibitors - therapeutic use ; Cardiovascular Diseases - complications ; Cardiovascular Diseases - drug therapy ; Chronic Disease ; Diabetes Complications ; Diabetes Mellitus - drug therapy ; Drug Interactions ; Female ; Glaucoma, Open-Angle - complications ; Glaucoma, Open-Angle - drug therapy ; Hormones - therapeutic use ; Humans ; Hypothyroidism - complications ; Hypothyroidism - drug therapy ; Male ; Middle Aged ; Practice Guidelines as Topic ; Retrospective Studies</subject><ispartof>Journal of glaucoma, 1997-12, Vol.6 (6), p.377-383</ispartof><rights>Williams & Wilkins 1997. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4217-14d66399b9d682fa6c1a1784e5835c294aeb89619cc3f77a31668ad4cd1ab7363</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9407366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gottfredsdottir, Maria S</creatorcontrib><creatorcontrib>Allingham, R Rand</creatorcontrib><creatorcontrib>Shields, M Bruce</creatorcontrib><title>Physiciansʼ Guide to Interactions Between Glaucoma and Systemic Medications</title><title>Journal of glaucoma</title><addtitle>J Glaucoma</addtitle><description>PURPOSETo develop a Physiciansʼ Guide to assist clinicians in the concomitant use of glaucoma and systemic medications.
METHODSThe records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed in this population. The ten most common drug classes were then used to construct a guide to potential interactions and side effects when these medications are used concomitantly with glaucoma drugs.
RESULTSEighty-four patients were receiving 1 or more medications (a mean of 3.5) for a mean of 2.6 systemic conditions. Systemic antihypertensive agents was the most common class of drugs, being used by 48 patients. Aspirin, the most common single systemic drug, was being used by 25 patients.
CONCLUSIONSA high percentage of patients with chronic open-angle glaucoma receive a wide variety of medications for coexisting systemic disorders. The concomitant use of glaucoma and systemic medications creates the potential for drug interactions, as well as side effects for both groups of drugs, for which the Physiciansʼ Guide may be beneficial.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Anticoagulants - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Carbonic Anhydrase Inhibitors - therapeutic use</subject><subject>Cardiovascular Diseases - complications</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Chronic Disease</subject><subject>Diabetes Complications</subject><subject>Diabetes Mellitus - drug therapy</subject><subject>Drug Interactions</subject><subject>Female</subject><subject>Glaucoma, Open-Angle - complications</subject><subject>Glaucoma, Open-Angle - drug therapy</subject><subject>Hormones - therapeutic use</subject><subject>Humans</subject><subject>Hypothyroidism - complications</subject><subject>Hypothyroidism - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Practice Guidelines as Topic</subject><subject>Retrospective Studies</subject><issn>1057-0829</issn><issn>1536-481X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kN1KAzEQhYMotVYfQcgLrGaSbH4utWgtVBRU8C5kkyxd3Z-y2aX03XwCn8q1rb3zYpgZzpzD8CGEgVwB0fKaECIAtEpAawl0WJOhiDxCY0iZSLiC9-NhJqlMiKL6FJ3F-EEIJZTCCI00J5IJMUaL5-UmFq6wdfz-wrO-8AF3DZ7XXWit64qmjvg2dOsQajwrbe-aymJbe_yyiV2oCocfgy-c3V6eo5PcljFc7PsEvd3fvU4fksXTbD69WSSOU5AJcC8E0zrTXiiaW-HAglQ8pIqljmpuQ6a0AO0cy6W0DIRQ1nPnwWbD22yC1C7XtU2MbcjNqi0q224MEPPLx_zxMQc-ZstnsF7urKs-q4I_GPdABp3v9HVTDgjiZ9mvQ2uWwZbd0vyHnf0Ad0Zwwg</recordid><startdate>199712</startdate><enddate>199712</enddate><creator>Gottfredsdottir, Maria S</creator><creator>Allingham, R Rand</creator><creator>Shields, M Bruce</creator><general>Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199712</creationdate><title>Physiciansʼ Guide to Interactions Between Glaucoma and Systemic Medications</title><author>Gottfredsdottir, Maria S ; Allingham, R Rand ; Shields, M Bruce</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4217-14d66399b9d682fa6c1a1784e5835c294aeb89619cc3f77a31668ad4cd1ab7363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Anticoagulants - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Carbonic Anhydrase Inhibitors - therapeutic use</topic><topic>Cardiovascular Diseases - complications</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Chronic Disease</topic><topic>Diabetes Complications</topic><topic>Diabetes Mellitus - drug therapy</topic><topic>Drug Interactions</topic><topic>Female</topic><topic>Glaucoma, Open-Angle - complications</topic><topic>Glaucoma, Open-Angle - drug therapy</topic><topic>Hormones - therapeutic use</topic><topic>Humans</topic><topic>Hypothyroidism - complications</topic><topic>Hypothyroidism - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Practice Guidelines as Topic</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gottfredsdottir, Maria S</creatorcontrib><creatorcontrib>Allingham, R Rand</creatorcontrib><creatorcontrib>Shields, M Bruce</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of glaucoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gottfredsdottir, Maria S</au><au>Allingham, R Rand</au><au>Shields, M Bruce</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physiciansʼ Guide to Interactions Between Glaucoma and Systemic Medications</atitle><jtitle>Journal of glaucoma</jtitle><addtitle>J Glaucoma</addtitle><date>1997-12</date><risdate>1997</risdate><volume>6</volume><issue>6</issue><spage>377</spage><epage>383</epage><pages>377-383</pages><issn>1057-0829</issn><eissn>1536-481X</eissn><abstract>PURPOSETo develop a Physiciansʼ Guide to assist clinicians in the concomitant use of glaucoma and systemic medications.
METHODSThe records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed in this population. The ten most common drug classes were then used to construct a guide to potential interactions and side effects when these medications are used concomitantly with glaucoma drugs.
RESULTSEighty-four patients were receiving 1 or more medications (a mean of 3.5) for a mean of 2.6 systemic conditions. Systemic antihypertensive agents was the most common class of drugs, being used by 48 patients. Aspirin, the most common single systemic drug, was being used by 25 patients.
CONCLUSIONSA high percentage of patients with chronic open-angle glaucoma receive a wide variety of medications for coexisting systemic disorders. The concomitant use of glaucoma and systemic medications creates the potential for drug interactions, as well as side effects for both groups of drugs, for which the Physiciansʼ Guide may be beneficial.</abstract><cop>United States</cop><pub>Williams & Wilkins</pub><pmid>9407366</pmid><doi>10.1097/00061198-199712000-00007</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1057-0829 |
| ispartof | Journal of glaucoma, 1997-12, Vol.6 (6), p.377-383 |
| issn | 1057-0829 1536-481X |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00061198_199712000_00007 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adrenergic beta-Antagonists - therapeutic use Adult Aged Aged, 80 and over Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Anticoagulants - therapeutic use Antihypertensive Agents - therapeutic use Carbonic Anhydrase Inhibitors - therapeutic use Cardiovascular Diseases - complications Cardiovascular Diseases - drug therapy Chronic Disease Diabetes Complications Diabetes Mellitus - drug therapy Drug Interactions Female Glaucoma, Open-Angle - complications Glaucoma, Open-Angle - drug therapy Hormones - therapeutic use Humans Hypothyroidism - complications Hypothyroidism - drug therapy Male Middle Aged Practice Guidelines as Topic Retrospective Studies |
| title | Physiciansʼ Guide to Interactions Between Glaucoma and Systemic Medications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A40%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physicians%CA%BC%20Guide%20to%20Interactions%20Between%20Glaucoma%20and%20Systemic%20Medications&rft.jtitle=Journal%20of%20glaucoma&rft.au=Gottfredsdottir,%20Maria%20S&rft.date=1997-12&rft.volume=6&rft.issue=6&rft.spage=377&rft.epage=383&rft.pages=377-383&rft.issn=1057-0829&rft.eissn=1536-481X&rft_id=info:doi/10.1097/00061198-199712000-00007&rft_dat=%3Cpubmed_cross%3E9407366%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9407366&rfr_iscdi=true |